Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shu-ichi Okamoto
Observed names:
S.-I. Okamoto,
S.-i. Okamoto
Institution:
Sanford Burnham Prebys Medical Discovery Institute
Observed institutions:
Brigham and Women's Hospital,
Harvard University,
Iwate University,
Sanford Burnham Prebys Medical Discovery Institute,
Osaka City University,
Gifu University
show all 6
OpenAlex ID:
A5111573784
Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophillic phase II inducers
2006
·
T. Satoh
, S.-i. Okamoto
, et al.
·
Proceedings of the National Academy of Sciences
·
361
Antiapoptotic role of the p38 mitogen-activated protein kinase–myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation
2000
·
Shu-ichi Okamoto
, Dimitri Krainc
, et al.
·
Proceedings of the National Academy of Sciences
·
204
Synergistic Activation of theN-Methyl-d-aspartate Receptor Subunit 1 Promoter by Myocyte Enhancer Factor 2C and Sp1
1998
·
Dimitri Krainc
, Guang Bai
, et al.
·
Journal of Biological Chemistry
·
101
Myocyte Enhancer Factor 2C as a Neurogenic and Antiapoptotic Transcription Factor in Murine Embryonic Stem Cells
2008
·
Z. Li
, S. R. McKercher
, et al.
·
Journal of Neuroscience
·
83
PDF
How Are Neuronal Genes Expressed in Neurons? Regulation of NMDA Receptor Subunit Type 1 Gene as a Model
2000
·
S.-I. Okamoto
, K. Sherman
, et al.
·
Springer eBooks
Show more works
View as search
Works count:
5
Citation count:
748
H-index:
4
I10-index:
4
Year
Topic
Type